LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,624 Cr | ₹602 Cr | ₹666 Cr | ₹994 Cr | ₹911 Cr |
What is the latest Cash Flow from Operating Activities ratio of LAURUS LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,624 Cr |
| Mar2025 | ₹602 Cr |
| Mar2024 | ₹666 Cr |
| Mar2023 | ₹994 Cr |
| Mar2022 | ₹911 Cr |
How is Cash Flow from Operating Activities of LAURUS LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,624 Cr | 169.84 | |
| Mar2025 | ₹602 Cr | -9.62 | |
| Mar2024 | ₹666 Cr | -33.02 | |
| Mar2023 | ₹994 Cr | 9.09 | |
| Mar2022 | ₹911 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹83,995.7 Cr | 3.4% | 11.9% | 100.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 3.4% |
11.9% |
100.5% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses